Oncologists In The Middle: Cancer Therapies And Cancer Costs
Oncologists, trained to consider the clinical implications of their decisions, are unavoidably placed in the middle of an economic predicament. To what extent should economic considerations be a factor in prescribing decisions? In the world of medicine, this dilemma is not peculiar to cancer, but with no other disease are the stakes as frequently or as starkly presented.
